Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities.

Violence perpetrated against unarmed patients is common in health care, and evidence-based safety measures are needed to acknowledge and eradicate clinical violence.

Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness.

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

COVID-19 underscores historical precedent for fear-driven responses that disregard autonomy among persons with low income who are also persons of color.

Little claims data exists upon which to make informed decisions about loss control or to draw upon when developing risk mitigation strategies.

Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions.

Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation.

During one 2014 Ebola epidemic, arrival of “safe burial” teams was often delayed. Some buried their loved ones themselves, which undermined containment efforts.